Bristol-Myers Squibb Company (BMY)

Number of days of payables

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Payables turnover		8.79	8.69	7.88	8.23	8.63	10.08	9.25	8.84	9.36	11.42	10.24	10.04	10.24	9.08	5.58	5.30	4.34	4.65	3.73	3.23
Number of days of payables	days	41.51	42.03	46.32	44.37	42.27	36.20	39.44	41.29	39.01	31.95	35.63	36.36	35.66	40.18	65.41	68.84	84.11	78.46	97.81	112.97

December 31, 2024 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 8.79
= 41.51

The number of days of payables for Bristol-Myers Squibb Company has exhibited a declining trend over recent periods, indicating an improvement in the company's ability to pay its suppliers in a timely manner. As of December 31, 2024, the number of days of payables stood at 41.51 days, suggesting that on average, the company takes approximately 41.51 days to pay its outstanding obligations to suppliers.

The gradual decrease in the number of days of payables from 112.97 days on March 31, 2020, to 41.51 days on December 31, 2024, reflects a more efficient management of payables by Bristol-Myers Squibb. This trend could be indicative of better cash flow management, negotiation strategies with suppliers, or operational improvements within the company's supply chain processes.

A lower number of days of payables typically signifies that the company is able to leverage favorable credit terms with its suppliers, enhance liquidity position, and potentially strengthen relationships with key vendors. However, it is important to monitor this metric alongside other financial indicators to gain a comprehensive understanding of the company's overall financial health and operational efficiency.